These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18835714)

  • 1. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
    Rechsteiner MP; Bernasconi M; Berger C; Nadal D
    Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
    Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
    J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
    Ikeda M; Ikeda A; Longan LC; Longnecker R
    Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein 2A and autoimmunity.
    Swanson-Mungerson M; Longnecker R
    Trends Immunol; 2007 May; 28(5):213-8. PubMed ID: 17398159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent Membrane Protein 2 (LMP2).
    Cen O; Longnecker R
    Curr Top Microbiol Immunol; 2015; 391():151-80. PubMed ID: 26428374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
    Portis T; Cooper L; Dennis P; Longnecker R
    Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
    Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
    J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
    Middeldorp JM; Pegtel DM
    Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.